| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.23 | 5e-13 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.2 | 3e-10 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.19 | 7e-10 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.21 | 8e-10 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-09 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.22 | 4e-09 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.2 | 1e-08 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-08 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.2 | 3e-08 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.19 | 4e-08 |